The health ministry also approved adding "cannabis extract (extract obtained from plants and parts of plants belonging to the species cannabis) in preparations approved as medicines" to Annex III of the drug law. That means that Sativex, a sublingual marijuana extract composed primarily of the compounds Tetrahydrocannabinol (THC) and Cannabidiol, will qualify as medicine under German law, and that its maker, Britain-based GW Pharma, can now apply to market it there.
Click title to continue article...
Of couse big pharma can do this. Well I shouldn't say of course because that is implicitly supporting it. But when money has this kind of pull...
No comments:
Post a Comment